Long-term Results of Enterprise Stent-Assisted Coiling of Cerebral Aneurysms
- 1 August 2012
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurosurgery
- Vol. 71 (2), 239-244
- https://doi.org/10.1227/neu.0b013e3182571953
Abstract
The Enterprise Vascular Reconstruction Device and Delivery System (Cordis; the Enterprise stent) was approved for use in conjunction with coiling of wide-necked aneurysms in 2007. No published long-term aneurysm occlusion or complication data exist for the Enterprise system. We compiled data on consecutive patients treated with Enterprise stent-assisted coiling of aneurysms from 9 high-volume neurointerventional centers. A 9 center registry was created to evaluate large volume data on the delayed safety and efficacy of the Enterprise stent system. Pooled data were compiled for consecutive patients undergoing Enterprise stent-assisted coiling at each institution prior to May 2009. Two-hundred twenty-nine patients with 229 aneurysms, 32 of which were ruptured aneurysms, were included in the study. Mean clinical and angiographic follow-up was 619.6 ± 26.4 days and 655.7 ± 25.2 days, respectively. Mean aneurysm size was 9.2 ± 0.4 mm. Fifty-nine percent of patients demonstrated 100% coil obliteration and 81% had 90% or higher occlusion at last follow-up angiography. A total of 19 patients (8.3%) underwent retreatment of their aneurysms during the follow-up period. Angiographic in-stent stenosis was seen in 3.4% and thromboembolic events occurred in 4.4%. Overall, 90% of patients who underwent Enterprise-assisted coiling had a modified Rankin Scale score of 2 or less at last follow-up. A poor modified Rankin Scale score was strongly associated with rupture status (P < .001). Although this study is limited by its retrospective nature, the Enterprise stent system appears to be an effective, safe, and durable treatment for intracranial aneurysms when used in conjunction with coiling.Keywords
This publication has 25 references indexed in Scilit:
- Results of endovascular treatment for intracranial wide-necked saccular and dissecting aneurysms using the Enterprise stent: A single center experienceEuropean Journal of Radiology, 2012
- Delayed Thrombosis or Stenosis Following Enterprise-Assisted Stent-Coiling: Is It Safe? Midterm Results of the Interstate Collaboration of Enterprise Stent CoilingNeurosurgery, 2011
- Treatment of intracranial aneurysms with the Enterprise stent: a multicenter registryJournal of Neurosurgery, 2009
- NEUROFORM STENT-ASSISTED COIL EMBOLIZATION OF WIDE-NECK INTRACRANIAL ANEURYSMSNeurosurgery, 2007
- A new self-expanding nitinol stent (Enterprise) for the treatment of wide-necked intracranial aneurysms: initial clinical and angiographic results in 31 aneurysmsNeuroradiology, 2007
- Stent-assisted coil embolization of intracranial wide-necked aneurysmsNeuroradiology, 2005
- Usefulness of the Neuroform Stent for the Treatment of Cerebral Aneurysms: Results at Initial (3–6-mo) Follow-upNeurosurgery, 2005
- Stent-assisted coil placement for unruptured cerebral aneurysmsNeurosurgical Focus, 2004
- ENDOVASCULAR OCCLUSION OF WIDE-NECKED ANEURYSMS WITH A NEW INTRACRANIAL MICROSTENT (NEUROFORM) AND DETACHABLE COILSNeurosurgery, 2004
- Preliminary Experience Using the Neuroform Stent for the Treatment of Cerebral AneurysmsNeurosurgery, 2004